# Heart Failure Mortality Prediction Model Summary

## Executive Summary

This model predicts the risk of death (DEATH_EVENT) in patients with heart failure using clinical and demographic features. It demonstrates good discrimination with an AUC of approximately 0.86 and solid accuracy around 82%, indicating reliable performance in distinguishing between patients who survive and those who do not. The underlying dataset is generally complete and consistent but contains several outliers and about 10% anomalous cases, which may affect model robustness.

## Performance

- **AUC:** 0.859
- **Accuracy:** 0.817
- **F1 score (positive class):** 0.667

The model shows strong ability to differentiate between patients who will experience death and those who will not, as reflected by the AUC near 0.86. Accuracy above 80% suggests that the model correctly classifies most cases overall. The F1 score of 0.67 indicates a balanced performance in identifying positive cases (deaths), though there is room for improvement in sensitivity and precision.

## Feature Importance

Feature importance is derived from SHAP values, which quantify each feature's contribution to the model's predictions. The most influential feature is 'time', where longer follow-up times relate to risk assessment. Lower 'ejection_fraction' values increase mortality risk, reflecting poorer heart function. Elevated 'serum_creatinine' levels, indicating impaired kidney function, also raise risk. Older age and presence of diabetes further increase predicted risk. Other features such as 'sex', 'creatinine_phosphokinase', 'serum_sodium', 'smoking', and 'platelets' contribute to risk but to a lesser extent.

## Data Quality Considerations

The data quality status is WARN due to the presence of multiple outliers and approximately 10% of rows flagged as anomalous by IsolationForest. Notable outliers exist in key clinical variables like 'creatinine_phosphokinase', 'serum_creatinine', and 'platelets', which may represent either data errors or true clinical extremes. These anomalies could impact model stability and interpretability, warranting cautious use and further investigation.

## Recommendations

Proceed with using the model while being mindful of the WARN data quality status. It is advisable to review and potentially cap or transform extreme outlier values to reduce their influence. Consider clinical validation of anomalous cases to determine if they represent valid rare events or data issues. Monitoring model performance on new data and retraining with cleaned or augmented datasets may improve robustness. Users should be cautious interpreting predictions for cases with extreme feature values or flagged anomalies.
